Ten years of proteomics in multiple sclerosis
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis, which is the most common cause of chronic neurological disability in young adults, is an inflammatory, demyelinating, and neurodegenerative disease of the CNS, which leads to the formation of multiple foci of demyelinated lesions in the white matter. The diagnosis is based currently on magnetic resonance image and evidence of dissemination in time and space. However, this could be facilitated if biomarkers were available to rule out other disorders with similar symptoms as well as to avoid cerebrospinal fluid analysis, which requires an invasive collection. Additionally, the molecular mechanisms of the disease are not completely elucidated, especially those related to the neurodegenerative aspects of the disease. The identification of biomarker candidates and molecular mechanisms of multiple sclerosis may be approached by proteomics. In the last 10 years, proteomic techniques have been applied in different biological samples ( CNS tissue, cerebrospinal fluid, and blood) from multiple sclerosis patients and in its experimental model. In this review, we summarize these data, presenting their value to the current knowledge of the disease mechanisms, as well as their importance in identifying biomarkers or treatment targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Proteomics approach has been widely adopted in studies of human diseases including cancer (Frantzi et al., 2015; S. Pan, Brentnall, & Chen, 2015; Petricoin et al., 2002; Tsai et al., 2015), multiple sclerosis (Farias, Pradella, Schmitt, Santos, & Martins-de-Souza, 2014) and schizophrenia (Al Awam et al., 2015; Nascimento & Martins-de-Souza, 2015).”
From Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases (2016) · cites this paper as Farias et al., 2014
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 1×
“However, recent studies have noted the role of Th17 cells in the pathogenesis of EAE and other autoimmune diseases [37–39].”
ResultAnderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
Wing, K., & Sakaguchi, S. (2010) · Nature Immunology · doi:10.1038/ni.1818 · Cited by 1,107
Vitamin D intake and incidence of multiple sclerosis
Munger, K. L., Zhang, S. M., O’Reilly, E., Hernán, M. A., Olek, M. J., Willett, W. C., & Ascherio, A. (2004) · Neurology · doi:10.1212/01.wnl.0000101723.79681.38 · Cited by 1,093
Progressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033 · cited 1×
“A smaller percentage of individuals (∼10–15%) develop a primary progressive form of multiple sclerosis [1,2,5,6].”
BackgroundAutoimmune T cell responses in the central nervous system
Goverman, J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2550 · Cited by 1,030
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
Perretti, M., & D'Acquisto, F. (2009) · Nature Reviews Immunology · doi:10.1038/nri2470 · Cited by 915
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
Reactive Astrocytes in Neural Repair and Protection
Sofroniew, M. V. (2005) · The Neuroscientist · doi:10.1177/1073858405278321 · Cited by 742
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Bartholomäus, I., Kawakami, N., Odoardi, F., Schläger, C., Miljkovic, D., Ellwart, J. W., Klinkert, W. E. F., Flügel-Koch, C., Issekutz, T. B., Wekerle, H., et al. (2009) · Nature · doi:10.1038/nature08478 · Cited by 685 · cited 2×
“The effector phase of the disease is characterized by the migration of auto-aggressive CD4+ T cells into the CNS and by the release of proinflammatory cytokines [36,40].”
BackgroundGray matter atrophy in multiple sclerosis: A longitudinal study
Fisher, E., Lee, J., Nakamura, K., & Rudick, R. A. (2008) · Annals of Neurology · doi:10.1002/ana.21436 · Cited by 670
Haines, J. L., Ter-Minassian, M., Bazyk, A., Gusella, J. F., Kim, D. J., Terwedow, H., PericakVance, M. A., Rimmler, J. B., Haynes, C. S., Roses, A. D., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-469 · Cited by 651
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS
Rivers, T. M., Sprunt, D. H., & Berry, G. P. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.58.1.39 · Cited by 643
ANTIGEN PROCESSING AND PRESENTATION BY THE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX
York, I. A., & Rock, K. L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.369 · Cited by 610
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Rosenberg, G. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70016-x · Cited by 594
Genetics of multiple sclerosis
Dyment, D. A., Ebers, G. C., & Dessa Sadovnick, A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00663-x · Cited by 563
The distribution of plaques in the cerebrum in multiple sclerosis
Brownell, B., & Hughes, J. T. (1962) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.25.4.315 · Cited by 543
Proteomic identification of nitrated proteins in Alzheimer's disease brain
Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B., Markesbery, W. R., & Butterfield, D. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01786.x · Cited by 535
Gray matter atrophy is related to long‐term disability in multiple sclerosis
Fisniku, L. K., Chard, D. T., Jackson, J. S., Anderson, V. M., Altmann, D. R., Miszkiel, K. A., Thompson, A. J., & Miller, D. H. (2008) · Annals of Neurology · doi:10.1002/ana.21423 · Cited by 500
Nylander, A., & Hafler, D. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58649 · Cited by 495
Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability
De Stefano, N., Matthews, P. M., Filippi, M., Agosta, F., De Luca, M., Bartolozzi, M. L., Guidi, L., Ghezzi, A., Montanari, E., Cifelli, A., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000055926.69643.03 · Cited by 489
The origin and application of experimental autoimmune encephalomyelitis
Baxter, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2190 · Cited by 458
MacLeod (2008) · Bristol Research (University of Bristol) · doi:10.4049/jimmunol · Cited by 448
Bench to Bedside: The Development of Rapamycin and Its Application to Stent Restenosis
Marx, S. O., & Marks, A. R. (2001) · Circulation · doi:10.1161/01.cir.104.8.852 · Cited by 447
Flügel, A., Berkowicz, T., Ritter, T., Labeur, M., Jenne, D. E., Li, Z., Ellwart, J. W., Willem, M., Lassmann, H., & Wekerle, H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00143-1 · Cited by 431
Apolipoprotein e sets the stage: response to injury triggers neuropathology
Mahley, R. W., & Huang, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.11.020 · Cited by 412
Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.
Geurts, J. J. G., Bø, L., Pouwels, P. J. W., Castelijns, J. A., Polman, C. H., & Barkhof, F. (2005) · PubMed · Cited by 407
Link, H., & Huang, Y.-M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.07.006 · Cited by 396
Calpain-Mediated Signaling Mechanisms in Neuronal Injury and Neurodegeneration
Vosler, P. S., Brennan, C. S., & Chen, J. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8036-x · Cited by 382
Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice
Emamaullee, J. A., Davis, J., Merani, S., Toso, C., Elliott, J. F., Thiesen, A., & Shapiro, A. M. J. (2009) · Diabetes · doi:10.2337/db08-1113 · Cited by 378
Dalton, C. M. (2004) · Brain · doi:10.1093/brain/awh126 · Cited by 377
Regional DTI differences in multiple sclerosis patients
ROOSENDAAL, S., GEURTS, J., VRENKEN, H., HULST, H., COVER, K., CASTELIJNS, J., POUWELS, P., & BARKHOF, F. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.026 · Cited by 370
APOE genotype-specific differences in the innate immune response
Vitek, M. P., Brown, C. M., & Colton, C. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.014 · Cited by 362
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci
Patsopoulos, N. A., the Bayer Pharma MS Genetics Working Group, T. S. C. O. S. E. I. A. A. C., & de Bakker, P. I. W. (2011) · Annals of Neurology · doi:10.1002/ana.22609 · Cited by 353
Evidence for genetic basis of multiple sclerosis
Sadovnick, A. D., the Canadian Collaborative Study Group, Dyment, D. A., Ebers, G. C., & Risch, N. J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90807-7 · Cited by 351
O'Connor, R. A., Prendergast, C. T., Sabatos, C. A., Lau, C. W. Z., Leech, M. D., Wraith, D. C., & Anderton, S. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3750 · Cited by 350
Gray matter involvement in multiple sclerosis
Pirko, I., Lucchinetti, C. F., Sriram, S., & Bakshi, R. (2007) · Neurology · doi:10.1212/01.wnl.0000250267.85698.7a · Cited by 349
Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
Srivastava, R., Aslam, M., Kalluri, S. R., Schirmer, L., Buck, D., Tackenberg, B., Rothhammer, V., Chan, A., Gold, R., Berthele, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110740 · Cited by 343
The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis
Reiber, H., Ungefehr, S., & Jacobi, C. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400304 · Cited by 317
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
Comabella, M., Fernández, M., Martin, R., Rivera-Vallvé, S., Borrás, E., Chiva, C., Julià, E., Rovira, A., Cantó, E., Alvarez-Cermeño, J. C., et al. (2010) · Brain · doi:10.1093/brain/awq035 · Cited by 300
Kuchroo, V. K., Martin, C. A., Greer, J. M., Ju, S. T., Sobel, R. A., & Dorf, M. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4371 · Cited by 276
Hafler, D. A., Slavik, J. M., Anderson, D. E., O'Connor, K. C., De Jager, P., & Baecher‐Allan, C. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00240.x · Cited by 260
Regulatory T cells and inhibitory cytokines in autoimmunity
Bettini, M., & Vignali, D. A. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.09.011 · Cited by 258
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
Norgren, N., Sundström, P., Svenningsson, A., Rosengren, L., Stigbrand, T., & Gunnarsson, M. (2004) · Neurology · doi:10.1212/01.wnl.0000142988.49341.d1 · Cited by 241
Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system
Nilsson, C., Lindvall-Axelsson, M., & Owman, C. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90011-a · Cited by 216
Proteomic analysis of multiple sclerosis cerebrospinal fluid
Hammack, B. N., Fung, K. Y., Hunsucker, S. W., Duncan, M. W., Burgoon, M. P., Owens, G. P., & Gilden, D. H. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1023oa · Cited by 182
Kroksveen, A. C., Opsahl, J. A., Aye, T. T., Ulvik, R. J., & Berven, F. S. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.11.010 · Cited by 176
Proteomics technologies for the global identification and quantification of proteins
Brewis, I. A., & Brennan, P. (2010) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/b978-0-12-381264-3.00001-1 · Cited by 171
Baranzini, S. E., Khankhanian, P., Patsopoulos, N. A., Li, M., Stankovich, J., Cotsapas, C., Søndergaard, H. B., Ban, M., Barizzone, N., Bergamaschi, L., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.019 · Cited by 163
Proteomic analysis of multiple sclerosis cerebrospinal fluid
Zhang, X. (2006) · Journal of Shandong University · Cited by 161
Pathogenetic role of autoantibodies in neurological diseases
Archelos, J. J., & Hartung, H. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01575-7 · Cited by 160
Flügel, A., Willem, M., Berkowicz, T., & Wekerle, H. (1999) · Nature Medicine · doi:10.1038/10567 · Cited by 156
Ray, S. K., & Banik, N. L. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482887 · Cited by 153
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Ottervald, J., Franzén, B., Nilsson, K. C., Andersson, L. I., Khademi, M., Eriksson, B., Kjellström, S., Marko‐Varga, G., Végvári, Á., Harris, R. A., et al. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.01.004 · Cited by 151
Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients
Dumont, D., Noben, J., Raus, J., Stinissen, P., & Robben, J. (2004) · PROTEOMICS · doi:10.1002/pmic.200300715 · Cited by 147
Altered immune responses in apolipoprotein E-deficient mice
Laskowitz, D. T., Lee, D. M., Schmechel, D., & Staats, H. F. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32409-3 · Cited by 147
Vitamin D 3 Induces IDO + Tolerogenic DC s and Enhances Treg, Reducing the Severity of EAE
Farias, A. S., Spagnol, G. S., Bordeaux‐Rego, P., de Oliveira, C. O. F., Fontana, A. G. M., de Paula, R. F. O., Santos, M. P. A., Pradella, F. M., Moraes, A. S., de Oliveira, E. C., et al. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12071 · Cited by 140
Self-citationType 1 Diabetes and Multiple Sclerosis
Nielsen, N. M., Westergaard, T., Frisch, M., Rostgaard, K., Wohlfahrt, J., Koch‐Henriksen, N., Melbye, M., & Hjalgrim, H. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.1001 · Cited by 124
Activated Self-MHC-Reactive T Cells Have the Cytokine Phenotype of Th3/T Regulatory Cell 1 T Cells
Kitani, A., Chua, K., Nakamura, K., & Strober, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.691 · Cited by 121
Genome-wide association study of severity in multiple sclerosis
International Multiple Sclerosis Genetics Consortium, Briggs, F. B. S., Shao, X., Goldstein, B. A., Oksenberg, J. R., Barcellos, L. F., & De Jager, P. L. (2011) · Genes & Immunity · doi:10.1038/gene.2011.34 · Cited by 120
Cerebrospinal fluid biomarkers in multiple sclerosis
Tumani, H., Hartung, H.-P., Hemmer, B., Teunissen, C., Deisenhammer, F., Giovannoni, G., & Zettl, U. K. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.04.010 · Cited by 120
Analysis of the mitochondrial proteome in multiple sclerosis cortex
Broadwater, L., Pandit, A., Clements, R., Azzam, S., Vadnal, J., Sulak, M., Yong, V. W., Freeman, E. J., Gregory, R. B., & McDonough, J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.012 · Cited by 117
Colten, H. R., & Rosen, F. S. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.004113 · Cited by 117
Multiple sclerosis: Is there neurodegeneration independent from inflammation?
Lassmann, H. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.08.016 · Cited by 116
Fabis, M. J., Scott, G. S., Kean, R. B., Koprowski, H., & Hooper, D. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701252104 · Cited by 99 · cited 1×
“In addition to the direct effect of inflammatory mediators on the myelin sheath, the release of proinflammatory cytokines inside the CNS increases the vascular permeability [45], which is considered an indirect effect of the proinflammatory cytokines on CNS homeostasis.”
BackgroundAutoantibody Profiling in Multiple Sclerosis Using Arrays of Human Protein Fragments
Ayoglu, B., Månberg, A., Khademi, M., Olsson, T. P., Uhlén, M., Schwenk, J. M., & Nilsson, P. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.026757 · Cited by 95
Carrier, Y., Yuan, J., Kuchroo, V. K., & Weiner, H. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.172 · Cited by 80
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination
Kang, Z., Liu, L., Spangler, R., Spear, C., Wang, C., Gulen, M. F., Veenstra, M., Ouyang, W., Ransohoff, R. M., & Li, X. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0841-12.2012 · Cited by 78
Cerebrospinal fluid proteome profile in multiple sclerosis
Lehmensiek, V., Süssmuth, S., Tauscher, G., Brettschneider, J., Felk, S., Gillardon, F., & Tumani, H. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507076406 · Cited by 77
Noben, J.-P., Dumont, D., Kwasnikowska, N., Verhaert, P., Somers, V., Hupperts, R., Stinissen, P., & Robben, J. (2006) · Journal of Proteome Research · doi:10.1021/pr0504788 · Cited by 76
Stoop, M. P., Singh, V. P., Dekker, L. J. M., Titulaer, M. K., Stingl, C., Burgers, P. C., Smitt, P. A. E. S., Hintzen, R. Q., & Luider, T. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012442 · Cited by 75
Multiple sclerosis‐related proteins identified in cerebrospinal fluid by advanced mass spectrometry
Stoop, M. P., Dekker, L. J., Titulaer, M. K., Burgers, P. C., Sillevis Smitt, P. A. E., Luider, T. M., & Hintzen, R. Q. (2008) · PROTEOMICS · doi:10.1002/pmic.200700446 · Cited by 74
New antigenic candidates in multiple sclerosis: Identification by serological proteome analysis
Alméras, L., Lefranc, D., Drobecq, H., Seze, J. D., Dubucquoi, S., Vermersch, P., & Prin, L. (2004) · PROTEOMICS · doi:10.1002/pmic.200300732 · Cited by 74
The prevalence of primary sjögren's syndrome in a multiple sclerosis population
Noseworthy, J. H., Bass, B., Vandervoort, M. K., Ebers, G. C., Rice, G. P., Weinshenker, B. G., McLay, C. J. L., & Bell, D. A. (1989) · Annals of Neurology · doi:10.1002/ana.410250117 · Cited by 74
Protein expression profiles in pediatric multiple sclerosis: potential biomarkers
Rithidech, K. N., Honikel, L., Milazzo, M. C., Madigan, D., Troxell, R. M., & Krupp, L. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508100047 · Cited by 72
von Glehn, F., Farias, A. S., de Oliveira, A. C. P., Damasceno, A., Longhini, A. L. F., de Oliveira, E. C., Damasceno, B. P., Santos, L. M., & Brandão, C. O. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511428465 · Cited by 68
Self-citationLiu, T., Donahue, K. C., Hu, J., Kurnellas, M. P., Grant, J. E., Li, H., & Elkabes, S. (2007) · Journal of Proteome Research · doi:10.1021/pr070012k · Cited by 66
Genomewide Study of Multiple Sclerosis
Ramagopalan, S. V., Anderson, C. A., Sadovnick, A. D., & Ebers, G. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmc072836 · Cited by 61
Genetics of multiple sclerosis: swimming in an ocean of data
Baranzini, S. E., & Nickles, D. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283533a93 · Cited by 61
Rosenling, T., Stoop, M. P., Attali, A., van Aken, H. H. M., Suidgeest, E., Christin, C., Stingl, C., Suits, F., Horvatovich, P. L., Hintzen, R. Q., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr201244t · Cited by 57
Sartori, S., Priante, E., Pettenazzo, A., Marson, P., Suppiej, A., Benini, F., Perilongo, G., & Toldo, I. (2013) · Journal of Child Neurology · doi:10.1177/0883073812469050 · Cited by 55
Characterization of the human serum depletome by label‐free shotgun proteomics
Koutroukides, T. A., Guest, P. C., Leweke, F. M., Bailey, D. M., Rahmoune, H., Bahn, S., & Martins‐de‐Souza, D. (2011) · Journal of Separation Science · doi:10.1002/jssc.201100060 · Cited by 52
Self-citationRajaseger, G., Lim, C. L., Wui, L., Saravanan, P., Tang, K., Gopalakrishnakone, P., Pen-huat, Y., Lu, J., & Moochhala, S. (2009) · Proteome Science · doi:10.1186/1477-5956-7-1 · Cited by 51
Plant, S. R., Iocca, H. A., Wang, Y., Thrash, J. C., O'Connor, B. P., Arnett, H. A., Fu, Y.-X., Carson, M. J., & Ting, J. P.-Y. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1307-07.2007 · Cited by 51
Haase, C. G., & Schmidt, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01949-8 · Cited by 50
Linker, R. A., Brechlin, P., Jesse, S., Steinacker, P., Lee, D. H., Asif, A. R., Jahn, O., Tumani, H., Gold, R., & Otto, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007624 · Cited by 49
Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
Liu, S., Bai, S., Qin, Z., Yang, Y., Cui, Y., & Qin, Y. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00850.x · Cited by 46
Farias, A. S., Talaisys, R. L., Blanco, Y. C., Lopes, S. C. P., Longhini, A. L. F., Pradella, F. M., dos Santos, L. M. B., & Costa, F. T. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017849 · Cited by 42
Self-citationJastorff, A. M., Haegler, K., Maccarrone, G., Holsboer, F., Weber, F., Ziemssen, T., & Turck, C. W. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800155 · Cited by 39
Affinity Depletion of Plasma and Serum for Mass Spectrometry-Based Proteome Analysis
Jaros, J. A. J., Guest, P. C., Bahn, S., & Martins‐de‐Souza, D. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-360-2_1 · Cited by 38
Self-citationImmunomodulatory treatment strategies in multiple sclerosis
Kieseier, B. C., Wiendl, H., Leussink, V. I., & Stüve, O. (2008) · Journal of Neurology · doi:10.1007/s00415-008-6004-z · Cited by 35
Ticozzi, N., Tiloca, C., Mencacci, N. E., Morelli, C., Doretti, A., Rusconi, D., Colombrita, C., Sangalli, D., Verde, F., Finelli, P., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6589-0 · Cited by 34
Vanheel, A., Daniels, R., Plaisance, S., Baeten, K., Hendriks, J. J. A., Leprince, P., Dumont, D., Robben, J., Brône, B., Stinissen, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035544 · Cited by 34
Ly, L., Barnett, M. H., Zheng, Y. Z., Gulati, T., Prineas, J. W., & Crossett, B. (2011) · Journal of Proteome Research · doi:10.1021/pr200672n · Cited by 34
Fainardi, E., Castellazzi, M., Tamborino, C., Trentini, A., Manfrinato, M., Baldi, E., Tola, M., Dallocchio, F., Granieri, E., & Bellini, T. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509102372 · Cited by 33
Proteomic technologies for biomarker studies in psychiatry: advances and needs.
Martins-de-Souza, D., Guest, P., Vanattou-Saifoudine, N., Harris, L., & Bahn, S. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00004-3 · Cited by 31
Self-citationTargeting cytosolic proliferating cell nuclear antigen in neutrophil-dominated inflammation
Chiara, A. D., Pederzoli-Ribeil, M., Burgel, P., Danel, C. J., & Witko‐Sarsat, V. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00311 · Cited by 31
Jain, M. R., Bian, S., Liu, T., Hu, J., Elkabes, S., & Hong Li, A. (2009) · Proteome Science · doi:10.1186/1477-5956-7-25 · Cited by 31
Nitric Oxide and TNFα Effects in Experimental Autoimmune Encephalomyelitis Demyelination
Farias, A. S., de la Hoz, C. L. R., Castro, F. R., de Oliveira, E. C., dos Reis, J. R. R., Silva, J. S., Langone, F., & dos Santos, L. M. B. (2007) · NeuroImmunoModulation · doi:10.1159/000107286 · Cited by 28
Self-citationDe Masi, R., Vergara, D., Pasca, S., Acierno, R., Greco, M., Spagnolo, L., Blasi, E., Sanapo, F., Trianni, G., & Maffia, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.03.002 · Cited by 26
Liu, J., Yin, L., Dong, H., Xu, E., Zhang, L., Qiao, Y., Liu, Y., Li, L., & Jia, J. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.05.002 · Cited by 25
Haghighi, S., Andersen, O., Nilsson, S., Rydberg, L., & Wahlström, J. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070972 · Cited by 22
Proteome analysis of brain in murine experimental autoimmune encephalomyelitis
Fazeli, S. A. S., Nasrabadi, D., Sanati, M. H., Pouya, A., Ibrahim, S. M., Baharvand, H., & Salekdeh, G. H. (2010) · PROTEOMICS · doi:10.1002/pmic.200900507 · Cited by 21
Dagley, L. F., Emili, A., & Purcell, A. W. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200104 · Cited by 20
Farias, A. S., Martins‐de‐Souza, D., Guimarães, L., Pradella, F., Moraes, A. S., Facchini, G., Novello, J. C., & Santos, L. M. B. (2012) · PROTEOMICS · doi:10.1002/pmic.201200044 · Cited by 18
Self-citationNeuropathy of Gastrointestinal Chagas’ Disease: Immune Response to Myelin Antigens
de Oliveira, E. C., Fujisawa, M. M., Longo, D. E. M. H., Farias, A. S., Moraes, J. C., Guariento, M. E., de Almeida, E. A., Saad, M. J. A., Langone, F., Toyama, M. H., et al. (2008) · NeuroImmunoModulation · doi:10.1159/000179667 · Cited by 17
Self-citationHsueh, C.-J., Kao, H.-W., Chen, S.-Y., Lo, C.-P., Hsu, C.-C., Liu, D.-W., & Hsu, W.-L. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.018 · Cited by 15
Apperson, M., Tian, Y., Stamova, B. S., Ander, B. P., Jickling, G. C., Agius, M. A., & Sharp, F. R. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.02.004 · Cited by 11
Pradella, F. M., Moraes, A. S., Santos, M. P. A., DePaula, R. F. O., Degaki, K., Longhini, A. L. F., Silva, V. D. R., dos Santos, L. M. B., & Farias, A. S. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12112 · Cited by 7
Self-citationIs clinical proteomics heading towards to “bench to bedside”?
(2013) · Translational Proteomics · doi:10.1016/j.trprot.2013.05.001 · Cited by 7
Cited by
Sun, Y. V., & Hu, Y.-J. (2016) · Advances in Genetics · doi:10.1016/bs.adgen.2015.11.004 · Cited by 459
“…sclerosis and schizophrenia have not established any reliable protein biomarkers to classify patients after years of investigation of different biological samples (e.g. CNS tissue, cerebrospinal fluid, peripheral blood, plasma and serum) (Farias et al., 2014; Nascimento & Martins-de-Souza, 2015).”
BackgroundAnoctamin 2 identified as an autoimmune target in multiple sclerosis
Ayoglu, B., Mitsios, N., Kockum, I., Khademi, M., Zandian, A., Sjöberg, R., Forsström, B., Bredenberg, J., Lima Bomfim, I., Holmgren, E., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518553113 · Cited by 111
“One of the main focus areas in MS research is the identification of molecular biomarker candidates, which would facilitate diagnosis and prognostic assessments in MS (9).”
BackgroundProteomics of protein post-translational modifications implicated in neurodegeneration
Ren, R.-J., Dammer, E. B., Wang, G., Seyfried, N. T., & Levey, A. I. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-23 · Cited by 63
Myelin: Methods for Purification and Proteome Analysis
Erwig, M. S., Hesse, D., Jung, R. B., Uecker, M., Kusch, K., Tenzer, S., Jahn, O., & Werner, H. B. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9072-6_3 · Cited by 64
Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?
Sen, M. K., Almuslehi, M. S. M., Shortland, P. J., Coorssen, J. R., & Mahns, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572186 · Cited by 55
Metadata
- Authors
- Farias, A. S., Pradella, F., Schmitt, A., Santos, L. M. B., & Martins‐de‐Souza, D.
- Affiliations
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Universidade de São Paulo (BR)
- Corresponding author
- Farias, Alessandro S.
- ORCID
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2014-03
- Volume
- 14
- Issue
- 4-5
- Pages
- 467-480
- ISSN
- 1615-9853 (ISSN-L)
- 1615-9861
- OpenAlex
- W2117929821
- Cited by
- 40
- References
- 116
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 7
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PROTEOMICS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- multiple sclerosis, biomarkers, demyelination, neurodegeneration, cerebrospinal fluid, blood-based biomarkers, disease mechanisms, treatment goals, central nervous system tissue
- MeSH terms
- Axons, Encephalomyelitis, Autoimmune, Experimental, Humans, Multiple Sclerosis, Biomarkers, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.